Liraglutide (Victoza, Saxenda) : Approved for type 2 diabetes (1.8 mg daily) and chronic weight management (3.0 mg daily)
"MOTS-c reduces myostatin and muscle atrophy signaling." American Journal of Physiology-Endocrinology and Metabolism
Please note: this product is strictly for laboratory use
Evidence signal Longevity research 6 source-backed citations are connected to this page
Dosage protocols and administration routes Effective protocols for penta deca peptide arginate vary based on the administration route, the condition being addressed, and individual factors like body weight and response sensitivity
Singh RB, Niaz MA, Agarwal P, Beegum R, Rastogi SS, Sachan DS: A randomised, double-blind, placebo-controlled trial of L-carnitine in suspected acute myocardial infarction